£2.4M
The healthcare artificial intelligence startup raised the capital from backers including MMC Ventures, Seedcamp, and Bayer G4A to scale operations globally.
"The inability of today's computers to understand doctors' unique way of writing has been a major issue. Doctors can correctly describe an 'infiltrating mass' without writing the word 'tumor' or write 'bilateral ground glass peripheral opacity' without explicitly indicating a suspicion for COVID-19"
A
Agamon—London, UKMMC Ventures + 3 others
